Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

Flaschen mit Blutproben
© DZIF/ScienceRelations

Transplant Cohort: First patients will be recruited

The DZIF Transplant Cohort, which was officially founded as an association in February 2014, has completed its preparations. The association can now begin with recruiting first patients and collecting

Enterobacter
© Inst. für Medizinische Mikrobiologie, JLU Gie

Mobile multidrug-resistance: A new dimension in hospital-acquired infections

Researchers from the German Center for Infection Research (DZIF) have confirmed the spread of a “multidrug-resistant plasmid” in a hospital. This plasmid is a mobile genetic element which can transfer

Preisträger 2014
© DZIF

The first ever DZIF prize goes to a hepatitis researcher

(26/11/2014) Virologist Stephan Urban from the University of Heidelberg will receive the DZIF Prize for Translational Infection Research, worth 5000 Euros. It will be awarded for the first time at the

Peter Kremsner
© DZIF/scienceRelations

Ebola vaccine trial initiated in Gabon

Researchers at the University of Tübingen are testing an Ebola vaccine in healthy adults in Gabon. The first voluntary trial participants are being vaccinated today.

(18/11/2014) Clinical phase I

Focussing on Ebola virus
© Philipps-Universität Marburg

Ebola: Clinical trials for a safe vaccine

A clinical phase I trial for a potential vaccine against the dreaded Ebola virus can now begin. The candidate vaccine has already successfully been tested in different animal models. The trial is

Ebola-Viren im Fokus
© Philipps-Universität Marburg

EBOKON: Strengthening Ebola Research

The German Center for Infection Research (DZIF) has initiated a consortium to strengthen Ebola research and close the knowledge gaps as quickly as possible in the fight against the epidemic. This

Tuberculosis bacteria
© CDC/James Archer

Tuberculosis: Better diagnosis in children

Rapid and reliable diagnosis of paediatric tuberculosis is still an ongoing problem. The most important prerequisite for successful treatment of active tuberculosis is its early diagnosis. A team of

Dirk Busch und sein Team
© TUM/Astrid Eckert

Individual central memory T cells are "multipotent"

Researchers in Germany and the U.S. have proven for the first time that specific individual cells of the immune system, termed central memory T cells, have all the essential characteristics of adult

Marburger Sicherheitslabor
© DZIF/scienceRELATIONS

Coronaviruses: Getting to a vaccine as fast as possible

At the German Center for Infection Research (DZIF), researchers are working intensively to make available a vaccine against the dreaded MERS coronavirus as soon as possible. A candidate vaccine has

Universitätsklinikum Freiburg
© Universitätsklinikum Freiburg

Less is more: Targeted reduction of antibiotic use in hospitals is possible

Antimicrobial resistance is a growing concern: Hospitals are increasingly being confronted with bacterial infections for which there is no cure. The frequent use of broad spectrum antibiotics, which